| |
| |
|
| Insider
Information: |
Quinn William P. |
| Relationship: |
Chief Financial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
163,969 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$144,741 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
163,969 |
|
|
| Total
Value |
$144,741 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -35.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
See Remarks |
2019-11-29 |
127,697 |
2018-12-10 |
0 |
Premium* |
|
|
Bolt Biotherapeutics, Inc. |
BOLT |
Chief Financial Officer |
2023-12-12 |
36,272 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-12 |
4 |
B |
$0.95 |
$7,125 |
D/D |
7,500 |
36,272 |
2.74 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-12-06 |
4 |
B |
$0.78 |
$1,955 |
D/D |
2,500 |
28,772 |
2.66 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2023-06-06 |
4 |
B |
$1.18 |
$2,161 |
D/D |
1,829 |
26,272 |
2.66 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-12-08 |
4 |
B |
$4.72 |
$23,575 |
D/D |
5,000 |
20,154 |
2.74 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-12-06 |
4 |
B |
$4.64 |
$162 |
D/D |
35 |
15,154 |
2.66 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-06-04 |
4 |
B |
$16.65 |
$20,330 |
D/D |
1,221 |
15,119 |
2.74 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-02-09 |
4 |
B |
$20.00 |
$24,000 |
D/D |
1,200 |
13,898 |
2.74 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Financial OfficerOfficer |
• – – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,698 |
|
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
See Remarks |
• – – |
2019-11-29 |
4 |
B |
$0.37 |
$2,193 |
D/D |
6,000 |
127,697 |
2.66 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
See Remarks |
• – – |
2019-05-31 |
4 |
B |
$0.65 |
$3,877 |
D/D |
6,000 |
121,697 |
2.66 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
See Remarks |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
63,697 |
115,697 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
CFO,Sr.V.P. Finance, Corp.Dev. |
• – – |
2018-12-10 |
4 |
B |
$0.47 |
$18,800 |
D/D |
40,000 |
52,000 |
2.74 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
